Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 134

Noom zooms to $540m series F

Samsung Ventures was part of a Silver Lake-led round that hiked health management app developer Noom's valuation to $3.7bn.

May 26, 2021

ANU helps pour $13.7m into Liquid Instruments

ANU Connect Ventures has participated in a series B round for Liquid Instruments, which builds on research at Australian National University.

May 26, 2021

Legend Capital lets in $270m for fund

Legend Holdings’s venture capital spinout has executed a secondary transaction to close its healthtech-oriented vehicle, LC Healthcare Continued Fund.

May 25, 2021

Eliem elicits $60m series B

Access Biotechnology has returned for a series B round raised by Eliem Therapeutics, which emerged from stealth with $80m only two months ago.

May 25, 2021

Imec.xpand initiates second fund

Imec's venture capital arm has received $36.7m in capital from the Flemish government for its sophomore fund.

May 24, 2021

Daily Deal Round Up: May 21, 2021

BioTheryX, Immuta and Pitch are among the companies that have raised fresh capital from corporates such as Intel Capital, Slack Fund, Citi Ventures and Dell Technologies Capital.

May 21, 2021

HiberCell hauls in series B financing

Bristol-Myers Squib and Mount Sinai Innovation Partners have helped the cancer therapeutics developer complete its series B round.

May 21, 2021

Giiant Pharma gears up for seed round

Theodorus has invested in Giiant Pharma’s $11m seed round.

May 21, 2021

Formlabs fashions $150m series E

SoftBank has led the series E round, doubling MIT Media Labs spinout Formlabs’ valuation to $2bn in the process.

May 20, 2021

Formlabs fashions $150m series E

SoftBank has led the series E round through its Vision Fund 2, doubling Formlabs’ valuation to $2bn in the process.

May 20, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here